Twitter | Search | |
Search Refresh
Jeffrey Patten 9h
Check out web site, Pipelines. is something they want as an inhaled drug! This could be epic for both companies. UTHR is hosting Science Day Monday Sept 24th. , CEO OF will be speaking!
Reply Retweet Like
MannKind Corporation Jan 25
“The secret to my success is that most people look at technology and say let’s go out and find a use for this technology. I typically do the reverse. I look for an unmet need and then find the technology to make it work.” -Alfred E. Mann founder of .
Reply Retweet Like
Laureen Oct 4
Including the letter I sent to appeal denial. For those w T1, you know what you live with daily better than anyone.
Reply Retweet Like
MannKind Corporation Jan 1
MannKind Corp wishes you a Happy New Year!
Reply Retweet Like
LeAnne Rooks May 15
Jake taking Afrezza at the shareholder dinner. .
Reply Retweet Like
LeAnne Rooks May 15
... eat what you love. And love what you eat.
Reply Retweet Like
MannKind Corporation Dec 14
"Diabetes is the greatest healthcare problem facing the world today. We need to find a solution to that."- Alfred. E Mann We are the makers of and are working to perfect the use of insulin for type 1 and 2 diabetes.
Reply Retweet Like
Duck Fiabetes NorCal Nov 10
Thank you & . You have changed my life. I went from Double digit A1'c and not caring to the best control I've ever had. I started in April 2015.
Reply Retweet Like
AfrezzaArmy Oct 9
Seen this? The word is spreading outside US... finally!
Reply Retweet Like
Andy Apr 24
Call me crazy-just bought more MNKD Why? 1.Technosphere undervalued asset when you realize it can be used for drugs that otherwise need refrigeration. 2.If AFREZZA approved in another country will be stock price bump. 3. Positive hi/low on balance vol
Reply Retweet Like
Jeffrey Patten Sep 20
I am surprised that more longs are not more excited about upcoming Science Day. I believe this is a great platform to spread awareness about Mnkd , maybe get coverage, upgrade & guidance on upcoming meds added to Technosphere.
Reply Retweet Like
Andy May 11
Wonder if Mannkind's Technosphere technology would have any efficacy in fighting lung cancer by getting tumor fighting drugs directly into the lungs.
Reply Retweet Like
Jeffrey Patten Oct 8
Reply Retweet Like
Abraham Ben Yiju Jun 26
Reply Retweet Like
John Monteleone May 5
Replying to @AfrezzaUS
never officially got my moms story in but she is a T2 that was on Humalog and metformin with A1C 11-13 and in 6 mon. on she was at 7.5. Now 11 mon. in she is just below 7! Amazing drug amazing company! From CEO to sales reps. They have been extremely helpful!
Reply Retweet Like
John Monteleone May 5
Replying to @sparkrov @AfrezzaUS
So now it’s my mission to get my mothers BG on track and once I heard about I knew I had to have her try it. Obviously whatever she was doing wasn’t working. . It’s a shame her Old Endo was “ok” with 11-13 A1C 🤦🏻‍♂️
Reply Retweet Like
Steven Rodriguez Feb 28
Replying to @RooksLeAnne @YouTube
Son turns 18 on Friday 1st time to use the discount coupon Thanks Leanne! Thanks VDEX! Thanks
Reply Retweet Like
Jeffrey Patten Sep 12
Bought more today. God help the shorts. Not giving up my shares! 😁🤑🤑🤑
Reply Retweet Like
Richard Eidinger Feb 6
Congratulations to our client at Corporation for adding David Kendall MD, an expert in Diabetes/Insulin Therapy, as their Chief Medical Officer. We hope this will bring good things for patients everywhere.
Reply Retweet Like
Jeffrey Patten Feb 16
Replying to @BenYiju
Ben, each script is for one year of . Numbers are better then people think! Trust Mike C.
Reply Retweet Like